Wei Yao

机构：SciencePharma (Poland), University of California Davis Medical Center · ORCID：0000-0002-1198-1161

发表论文 114 篇 · 总被引 5792 次 · h-index 39

代表论文

• An efficient Agrobacterium-mediated transformation method using hypocotyl as explants for Brassica napus (2020 · Molecular Breeding · 被引 119)
• Development of an Orally Active Small-Molecule Inhibitor of Receptor Activator of Nuclear Factor-κB Ligand (2022 · Journal of Medicinal Chemistry · 被引 17)
• Association between admission albumin levels and 30-day readmission after hip fracture surgery in geriatric patients: a propensity score-matched study (2024 · BMC Musculoskeletal Disorders · 被引 13)
• The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma (2022 · Frontiers in Oncology · 被引 13)
• High Mannose N-Glycans Promote Migration of Bone-Marrow-Derived Mesenchymal Stromal Cells (2020 · International Journal of Molecular Sciences · 被引 13)
• Curcumin-loaded nanoscale coordination polymers for ROS scavenging and anti-inflammatory therapy in atherosclerosis (2025 · Materials Today Bio · 被引 11)